Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nonmyeloablative HSCT for Ph+ ALL and CML-BC
NCT00036738Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jul 2001
- Primary completion
- Jul 2014
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of peripheral blood stem cells in acute lymphoblastic leukemia (ALL), chronic myeloid leukemia (CML), sponsored by Fred Hutchinson Cancer Center. Started Jul 2001; status: completed.
02
Drugs
peripheral blood stem cells
03
Conditions
acute lymphoblastic leukemia (ALL)chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00036738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00036738.